儿童期β地中海贫血:高收入国家当前健康状况
基于法国国家登记库2005至2020年出生的237例β地中海贫血患儿数据,评估其健康状况;其中162例(68.4%)为重型表型,在法国出生的重型患儿15岁生存概率为98.3%,54例(22.8%)接受了造血干细胞移植且成功率为88.8%。
要点
- 在法国出生的重型β地中海贫血患儿15岁生存概率为98.3%。
- 54例(22.8%)患儿接受造血干细胞移植,成功率为88.8%。
- 未移植患者中肝脏和心脏中度铁过载分别占15.7%(18/115)和7.1%(7/99)。
核心结论
- 在高收入国家,儿童期β地中海贫血患者总体健康状况良好,生存率高,疾病对生长和学业成绩无显著影响。
研究设计与样本
- 基于法国国家登记库的回顾性数据收集,纳入2005年至2020年出生的β地中海贫血中间型(TI)或重型(TM)患儿,共分析237例,末次访视中位年龄7.1岁。
主要发现
- 237例患儿中156例(65.8%)在法国出生,162例(68.4%)为重型表型。
- 在法国出生的重型患儿15岁生存概率为98.3%。
- 54例(22.8%)患儿接受造血干细胞移植,成功率为88.8%。
- 未移植患者中肝脏中度铁过载占15.7%(18/115),心脏中度铁过载占7.1%(7/99);仅4例重型患儿出现临床并发症(肝脏3例)。
- 末次访视时平均铁蛋白为1293 ng/ml(±759);去铁酮是主要一线螯合剂,78.2%的病例使用,11.7%的病例报告副作用。
关键数值与推荐
- 总体不到10%的患儿接受脾切除术。
- 未观察到疾病对生长或学业成绩有显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
β-thalassemia is an haemoglobinopathy characterized by a defective synthesis of the β-globin chain. To assess the current state of health of paediatric patients with β-thalassemia, data from the French national registry regarding children born between 2005 and 2020 with β-thalassemia intermedia (TI) or major (TM) were collected. A total of 237 patients (median age 7.1 years at last visit) were analysed, of whom 156 (65.8%) were born in France and 162 (68.4%) had a TM phenotype. The probability of survival for children with TM born in France was 98.3% at 15 years. Fifty-four (22.8%) children received a haematopoietic stem cell transplant with a success rate of 88.8%. Hepatic and cardiac iron overload monitoring in non-transplanted patients showed moderate overload in 15.7% (18/115) and 7.1% (7/99) of cases, respectively, while clinical complications were found in only 4 patients with TM (hepatic in 3 cases). At last visit, mean ferritinemia was 1293 ng/ml (±759). Overall, less than 10% of children underwent splenectomy. No significant impact of the disease on growth or academic achievement was observed. Deferasirox was the main first-line chelator, prescribed in 78.2% of cases, with side effects reported in 11.7% of instances.
引用
- Donze C, Benoit A, Thuret I, et al. β-Thalassemia in childhood: Current state of health in a high-income country. Br J Haematol. 2023. PMID: 36606625. doi:10.1111/bjh.18631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。